Observational study following people with pancreatic cancer over time
Describes the real-world course of people with pancreatic cancer, including their treatment and outcomes.
Plain-language title generated from the registry record
Registry title: Observational Copenhagen Pancreatic Cancer Study
Key facts
- Where
- Herlev, DenmarkSee the site
Where in Denmark
- Department of OncologyHerlev, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Inna Chen, MD
- Trial code
- NCT06713525
- Record updated
- 4 September 2026
- Original description
The primary objective of the Copenhagen Pancreatic Cancer (COPAN) study is to describe the real-world population of patients with pancreatic cancer (PC). Larger sample of longitudinal real-world data provides a unique opportunity for comprehensive exploration of the diagnostic and treatment journey for individuals diagnosed with PC and allows to investigate treatment outcomes and associated prognostic factors. Furthermore, the study aims to identify determinants of treatment management and treatment outcomes, including patient-reported outcomes.Read full original descriptionShow less
Copenhagen Pancreatic Cancer Study (COPAN)
The primary objective of the Copenhagen Pancreatic Cancer (COPAN) study is to describe the real-world population of patients with pancreatic cancer (PC). Larger sample of longitudinal real-world data provides a unique opportunity for comprehensive exploration of the diagnostic and treatment journey for individuals diagnosed with PC and allows to investigate treatment outcomes and associated prognostic factors. Furthermore, the study aims to identify determinants of treatment management and treatment outcomes, including patient-reported outcomes.
Inclusion: Histologically confirmed pancreatic cancer.
Exclusion: None.